EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Treatment of concomitant myasthenia gravis and Lambert-Eaton myasthenic syndrome with autologous CD19-targeted CAR T cells

Jeremias Motte, Melissa Sgodzai, Christiane Schneider-Gold, Nina Steckel, Thomas Mika, Tobias Hegelmaier, Dominic Borie, Aiden Haghikia, Dimitrios Mougiakakos, Roland Schroers, Ralf Gold

Neuron · 2024

DOI: 10.1016/j.neuron.2024.04.014 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Neuron, 2024. Verfasst von Jeremias Motte und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, St. Josef-Hospital Bochum, Ruhr-University Bochum, 44791 Bochum, Germany. Hauptthemen laut MEDLINE: Lambert-Eaton Myasthenic Syndrome, Myasthenia Gravis, Antigens, CD19, Immunotherapy, Adoptive. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lambert-Eaton Myasthenic SyndromeMyasthenia GravisAntigens, CD19Immunotherapy, AdoptiveHumansFemaleMiddle AgedT-LymphocytesReceptors, Chimeric AntigenAdultTreatment Outcome

Stichwörter der Autor:innen

CARLEMSLambert-Eaton myasthenic syndromeMGT cell therapyanti-CD19 chimeric antigen receptorcase reportmyasthenia gravis

Substanzen

Antigens, CD19Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Department of Neurology, St. Josef-Hospital Bochum, Ruhr-University Bochum, 44791 Bochum, Germany.
  • Department of Hematology and Oncology, Ruhr-University Bochum, Knappschaftskrankenhaus, 44892 Bochum, Germany.
  • Department of Neurology, Otto-von-Guericke University, 39120 Magdeburg, Germany.
  • Kyverna Therapeutics, Emeryville, CA 94608, USA.
  • Department of Hematology and Oncology, Otto-von-Guericke University, 39120 Magdeburg, Germany.
  • Department of Hematology and Oncology, Ruhr-University Bochum, Knappschaftskrankenhaus, 44892 Bochum, Germany. Electronic address: roland.schroers@rub.de.

Zitieren

APA

Motte, J., Sgodzai, M., Schneider-Gold, C., Steckel, N., Mika, T., Hegelmaier, T., Borie, D., Haghikia, A., Mougiakakos, D., Schroers, R., & Gold, R. (2024). Treatment of concomitant myasthenia gravis and Lambert-Eaton myasthenic syndrome with autologous CD19-targeted CAR T cells. Neuron. https://doi.org/10.1016/j.neuron.2024.04.014

Vancouver

Motte J, Sgodzai M, Schneider-Gold C, Steckel N, Mika T, Hegelmaier T, et al. Treatment of concomitant myasthenia gravis and Lambert-Eaton myasthenic syndrome with autologous CD19-targeted CAR T cells. Neuron. 2024. doi:10.1016/j.neuron.2024.04.014

BibTeX
@article{Motte2024,
  author = {Motte, Jeremias and Sgodzai, Melissa and Schneider-Gold, Christiane and Steckel, Nina and Mika, Thomas and Hegelmaier, Tobias and Borie, Dominic and Haghikia, Aiden and Mougiakakos, Dimitrios and Schroers, Roland and Gold, Ralf},
  title = {Treatment of concomitant myasthenia gravis and Lambert-Eaton myasthenic syndrome with autologous CD19-targeted CAR T cells},
  journal = {Neuron},
  year = {2024},
  doi = {10.1016/j.neuron.2024.04.014}
}
Kostenlos starten →